Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMDEVIMAB for Covid-19 treatment: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where IMDEVIMAB was used for Covid-19 treatment.

Most Reported Side Effects for IMDEVIMAB

Side Effect Reports % Deaths Hosp.
Infusion related reaction 94 21.8% 1 29
Dyspnoea 84 19.4% 1 48
Nausea 48 11.1% 2 20
Covid-19 pneumonia 42 9.7% 3 40
Hypoxia 40 9.3% 2 32
Pyrexia 39 9.0% 1 26
Oxygen saturation decreased 34 7.9% 2 23
Vomiting 32 7.4% 2 13
Dizziness 31 7.2% 0 5
Cough 27 6.3% 1 15
Flushing 27 6.3% 0 4
Chest discomfort 26 6.0% 0 6
Chills 26 6.0% 2 17
Blood pressure increased 24 5.6% 1 10
Chest pain 22 5.1% 0 11

Other Indications for IMDEVIMAB

Covid-19 (322) Sars-cov-2 test positive (23) Coronavirus infection (5)

Other Drugs Used for Covid-19 treatment

NIRMATRELVIR\RITONAVIR (44,763) MOLNUPIRAVIR (3,476) CASIRIVIMAB\IMDEVIMAB (208) REMDESIVIR (156) CILGAVIMAB\TIXAGEVIMAB (146) BAMLANIVIMAB\ETESEVIMAB (85) HYDROXYCHLOROQUINE (71) SOTROVIMAB (69) BAMLANIVIMAB (66) DEXAMETHASONE (60)

Related Pages

IMDEVIMAB Full Profile All Covid-19 treatment Drugs IMDEVIMAB Demographics IMDEVIMAB Timeline